<p>Tomas Kalincik, Head of the Clinical Outcomes Research Unit at the University of Melbourne, explains his research comparing hematopoietic stem cell transplantation (HSCT) with existing treatments in relapsing and progressive MS. </p>

Tomas Kalincik, Head of the Clinical Outcomes Research Unit at the University of Melbourne, explains his research comparing hematopoietic stem cell transplantation (HSCT) with existing treatments in relapsing and progressive MS.

Stem Cell Research in Multiple Sclerosis

The world is better when its people are connected. The ECTRIMS Podcast aims to be a sounding board for MS experts & advocates to discuss innovative work in MS research, treatment and care with the greater MS research community, while offering a collaborative platform for MS and healthcare experts to promote & nurture the advancement of research.

Science

Medicine

Health & Fitness

The world is better when its people are connected. The ECTRIMS Podcast aims to be a sounding board for MS experts &amp; advocates to discuss innovative work in MS research, treatment and care with the greater MS research community, while offering a collaborative platform for MS and healthcare experts to promote &amp; nurture the advancement of research.

Share Stem Cell Research in Multiple Sclerosis

Sign up to save your podcasts

Stem Cell Research in Multiple Sclerosis

Stem Cell Research in Multiple Sclerosis

More shows like The ECTRIMS Podcast

Neurology® Podcast

Practical Neurology Podcast

In The Dark

The Daily

RealTalk MS

Shameless

Living Well with Multiple Sclerosis

Post Reports

The Journal.

MS Living Well: Key Info from Multiple Sclerosis Experts

ZOE Science & Nutrition

Continuum Audio